Guest

Dr. Michele De Luca has been involved in epithelial stem cell biology aimed at clinical applications in regenerative medicine for over 20 years. He joins the show to discuss his work and latest groundbreaking paper published in Nature.

Featured Resource: Growing Organoids from Stem Cells Wallchart

Resources and Links

New Tax Plan Closer to Passing and Impacting Science – If the new tax plan is enacted and passed, it could limit the ability of graduate students to complete their training programs and would particularly affect those students without other means to help support their studies.

Hospitals Can Help Opioid Addiction Epidemic – New opioid prescribing guidelines tested over a five-month period in Michigan kept thousands of opioid pills from being unnecessarily doled out.

When We Lock Eyes with a Baby, Our Brain Waves Sync Up – The baby’s and the adult’s brain activity appeared to get in sync by meeting in the middle.

SARS Bat Reservoirs – Genetic studies of viruses from horseshoe bats in one cave in China suggest the animals are reservoirs of SARS coronaviruses.

A New Way to Prevent Stem Cell Loss – A nutrient sensing pathway target of rapamycin (TOR) can be subdued in order to prevent stem cell loss.

114 Million Raised to Bring Stem Cell Trial for Diabetes to Humans – Semma Therapeutics, a company that got its start in 2014, and is researching ways to use stem cells that act like key cells responsible for regulating blood sugar levels in the bodies of healthy people has just raised $114 million.

Yamanaka Asks Fujifilm to Keep Licensing Fees Low – A noted Japanese stem cell researcher, Shinya Yamanaka, has asked Fujifilm Holdings to keep fees in check for using patented technology related to induced pluripotent stem cells.

Stem Cells and Gene Therapy Replace Entire Epidermis of Young Boy – A 7-year-old who lost most of his skin to a rare genetic disease has made a dramatic recovery after receiving an experimental gene therapy involving a whole-body graft of genetically modified stem cells which is the most ambitious attempt yet to treat a severe form of epidermolysis bullosa, an often-fatal group of conditions that cause skin to blister and tear off at the slightest touch.

Photo Reference: Courtesy of Dr. Michele De Luca